Extracellular Matrix and Matrix Metalloproteinases in Sciatic Nerve

Journal of Neuroscience Research

Volumn 74, Issue 3, 2003, Pages 417-429

  Platt, C I ^a   Krekoski, C A ^a   Ward, R V ^b   Edwards, D R ^a   Gavrilovic, J ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Extracellular matrix; Matrix metalloproteinases; PNS; Sciatic nerve; TIMP

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FEMALE; MOUSE; NERVE CRUSH; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE INJURY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; REVIEW; SCIATIC NERVE; ZYMOGRAPHY;

ANIMALS; ANIMALS, NEWBORN; DENSITOMETRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRONECTINS; FUNCTIONAL LATERALITY; GELATINASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOBLOTTING; LAMININ; MALE; METALLOPROTEASES; MICE; MICE, INBRED STRAINS; NERVE CRUSH; PHENANTHROLINES; PREGNANCY; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCIATIC NERVE; SPINAL CORD; TIME FACTORS;

EID: 0242267128     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10783     Document Type: Review

References (68)

1. Alfandari D, Cousin H, Gaultier A, Smith K, White JM, Darribere T, DeSimone DW. 2001. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest cell migration. Curr Biol 11:918-930.
2. Baker AH, Edwards DR, Murphy G. 2002. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115:3719-3727.
3. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB. 2002. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640.
4. Carey DJ, Eldridge CF, Cornbrooks CJ, Timpl R, Bunge RP. 1983. Biosynthesis of type IV collagen by cultured rat Schwann cells. J Cell Biol 97:473-479.
5. Chernousov MA, Stahl RC, Carey DJ. 1998. Schwann cells use a novel collagen-dependent mechanism for fibronectin fibril assembly. J Cell Sci 111:2763-2777.
6. Colognato H, Yurchenco PD. 2000. Form and function: the laminin family of heterotrimers. Dev Dyn 218:213-234.
7. Creange A, Sharshar T, Planchenault T, Christov C, Poron F, Raphael JC, Gherardi RK. 1999. Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre syndrome. Neurology 53:1683-1691.
8. Duchossoy Y, Horvat JC, Stettler O. 2001. MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites. Mol Cell Neurosci 17:945-956.
9. Edwards DR, Leco KJ, Beaudry PP, Atadja PW, Veillette C, Riabowol KT. 1996. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 31:207-223.
10. Fager N, Jaworski DM. 2000. Differential spatial distribution and temporal regulation of tissue inhibitor of metalloproteinase mRNA meta expression during rat central nervous system development. Mech Dev 98:105-109.
11. Ferguson TA, Muir D. 2000. MMP-2 and MMP-9 increase the neurite-promoting potential of Schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci 16:157-167.
12. Forsberg E, Hirsch E, Frohlich L, Meyer M, Ekblom P, Aszodi A, Werner S, Fassler R. 1996. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci USA 93:6594-6599.
13. Fu WM, Liou HH, Wang CL. 2001. Collaboration of fibronectin matrix and neurotrophin in regulating spontaneous transmitter release at developing neuromuscular synapses in Xenopus cell cultures. Neurosci Lett 300:115-119.
14. George EL, Baldwin HS, Hynes RO. 1997. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood 90:3073-3081.
15. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119:1079-1091.
16. Giraudon P, Szymocha R, Buart S, Bernard A, Cartier L, Belin MF, Akaoka H. 2000. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease. J Immunol 164:2718-2727.
17. Gustafsson E, Fassler R. 2000. Insights into extracellular matrix functions from mutant mouse models. Exp Cell Res 261:52-68.
18. Hartmann U, Maurer P. 2001. Proteoglycans in the nervous system - the quest for functional roles in vivo. Matrix Biol 20:23-35.
19. Hughes PM, Wells GM, Perry VH, Brown MC, Miller KM. 2002. Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience 113:273-287.
20. Jaworski J, Biedermann IW, Lapinska J, Szklarczyk A, Figiel I, Konopka D, Nowicka D, Filipkowski RK, Hetman M, Kowalczyk A, Kaczmarek L. 1999. Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. J Biol Chem 274:28106-28112.
21. Jiang X, Namura S, Nagata I. 2001. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 305:41-057 44.
22. Joester A, Faissner A. 1999. Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J Biol Chem 274:17144-17151.
23. Joester A, Faissner A. 2001. The structure and function of tenascins in the nervous system. Matrix Biol 20:13-22.
24. Kamiguchi H, Hlavin ML, Yamasaki M, Lemmon V. 1998. Adhesion molecules and inherited diseases of the human nervous system. Annu Rev Neurosci 21:97-125.
25. Kiernan BW, Garcion E, Ferguson J, Frost EE, Torres EM, Dunnett SB, Saga Y, Aizawa S, Faissner A, Kaur R, Franklin RJ, ffrench-Constant C. 1999. Myelination and behaviour of tenascin-C null transgenic mice. Eur J Neurosci 11:3082-3092.
26. Kieseier BC, Paul R, Koedel U, Seifert T, Clements JM, Gearing AJ, Pfister HW, Hartung HP. 1999. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122:1579-1587.
27. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G. 1997. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272:7608-7616.
28. Koshy PJ, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE. 2002. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 46:961-967.
29. Krull CE, Koblar SA. 2000. Motor axon pathfinding in the peripheral nervous system. Brain Res Bull 53:479-487.
30. Kvist AP, Latvanlehto A, Sund M, Horelli-Kuitunen N, Rehn M, Palotie A, Beier D, Pihlajaniemi T. 1999. Complete exon-intron organization and chromosomal location of the gene for mouse type XIII collagen (col13a1) and comparison with its human homologue. Matrix Biol 18:261-274.
31. Kvist AP, Latvanlehto A, Sund M, Eklund L, Vaisanen T, Hagg P, Sormunen R, Komulainen J, Fassler R, Pihlajaniemi T. 2001. Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy. Am J Pathol 159:1581-1592.
32. La Fleur M, Underwood JL, Rappolee DA, Werb Z. 1996. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184:2311-2326.
33. Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. 2001. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743-1753.
34. Luckenbill-Edds L. 1997. Laminin and the mechanism of neuronal out-growth. Brain Res Brain Res Rev 23:1-27.
35. Mackie EJ, Tucker RP. 1999. The tenascin-C knockout revisited. J Cell Sci 112:3847-3853.
36. Martin J, Eynstone LV, Davies M, Williams JD, Steadman R. 2002. The role of ADAM 15 in glomerular mesangial cell migration. J Biol Chem 277:33683-33689.
37. McKerracher L, Chamoux M, Arregui CO. 1996. Role of laminin and integrin interactions in growth cone guidance. Mol Neurobiol 12:95-116.
38. Messent AJ, Tuckwell DS, Knauper V, Humphries MJ, Murphy G, Gavrilovic J. 1998. Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. J Cell Sci 111:1127-1135.
39. Mirsky R, Jessen KR, Brennan A, Parkinson D, Dong Z, Meier C, Parmantier E, Lawson D. 2002. Schwann cells as regulators of nerve development. J Physiol Paris 96:17-24.
40. Muir D, Manthorpe M. 1992. Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation. J Cell Biol 116:177-185.
41. Murphy G, Gavrilovic J. 1999. Proteolysis and cell migration: creating a path? Curr Opin Cell Biol 11:614-621.
42. Murphy G, Stanton H, Cowell S, Butler G, Knauper V, Atkinson S, Gavrilovic J. 1999. Mechanisms for pro matrix metalloproteinase activation. APMIS 107:38-44.
43. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. 2002. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 22:7526-7535.
44. Nuttall RK, Pennington CJ, Taplin J, Wheal A, Yong VW, Forsyth PA, Edwards DR. 2003. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res 1:333-345.
45. Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z, Yong VW. 1999. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19:8464-8475.
46. Osawa T, Ide C. 1986. Changes in thickness of collagen fibrils in the. Acta Anat (Basel) 125:245-251.
47. Parmantier E, Lynn B, Lawson D, Turmaine M, Namini SS, Chakrabarti L, McMahon AP, Jessen KR, Mirsky R. 1999. Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron 23:713-724.
48. Perris R. 1997. The extracellular matrix in neural crest-cell migration. Trends Neurosci 20:23-31.
49. Powell SK, Kleinman HK. 1997. Neuronal laminins and their cellular receptors. Int J Biochem Cell Biol 29:401-414.
50. Previtali SC, Feltri ML, Archelos JJ, Quattrini A, Wrabetz L, Hartung H. 2001. Role of integrins in the peripheral nervous system. Prog Neurobiol 64:35-49.
51. Primakoff P, Myles DG. 2000. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 16:83-87.
52. Sanes JR, Engvall E, Butkowski R, Hunter DD. 1990. Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 111:1685-1699.
53. Shubayev VI, Myers RR. 2000. Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 855:83-89.
54. Shubayev VI, Myers RR. 2002. Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy. J Peripheral Nerv Syst 7:28-36.
55. Siebert H, Dippel N, Mader M, Weber F, Bruck W. 2001. Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol 60:85-93.
56. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
57. Stringa E, Knauper V, Murphy G, Gavrilovic J. 2000. Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells. J Cell Sci 113:2055-2064.
58. Sund M, Vaisanen T, Kaukinen S, Ilves M, Tu H, Autio-Harmainen H, Rauvala H, Pihlajaniemi T. 2001. Distinct expression of type XIII collagen in neuronal structures and other tissues during mouse development. Matrix Biol 20:215-231.
59. Uziyel Y, Hall S, Cohen J. 2000. Influence of laminin-2 on Schwann cell-axon interactions. Glia 32:109-121.
60. Vaillant C, Didier-Bazes M, Hutter A, Belin MF, Thomasset N. 1999. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 19:4994-5004.
61. Wall SJ, Edwards DR. 2002. Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRS. Anal Biochem 300:269-273.
62. Werb Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
63. Williams PE, Lowry A, Hill R, Masson E. 2000. Relationship between fascicle size and perineurial collagen IV content in diabetic and control human peripheral nerve. Histopathology 36:551-555.
64. Woessner JF, Nagase H. 2000. Matrix metalloproteinases and TIMPs. Oxford: Oxford University Press. 223 p.
65. Xiao ZC, Bartsch U, Margolis RK, Rougon G, Montag D, Schachner M. 1997. Isolation of a tenascin-R binding protein from mouse brain membranes. A phosphacan-related chondroitin sulfate proteoglycan. J Biol Chem 272:32092-2057 32101.
66. Yong VW, Power C, Forsyth P, Edwards DR. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502-511.
67. Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, Leco KJ, Clark IM, Edwards DR. 2002. Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J 364:89-99.
68. Zuo J, Ferguson TA, Hernandez YJ, Stetler-Stevenson WG, Muir D. 1998. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 18:5203-5211.